CHELMSFORD, Mass., Aug 23 (Bernama-BUSINESS WIRE) — ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Wallaby Medical Technologies, a medical device company dedicated to treating stroke and cardiac arrest, today announced they have signed a distribution agreement whereby Wallaby will manage the sales and distribution of ZOLL’s temperature management products in China.
In China, cardiac arrest and stroke account for more than 544,000¹ and 1.79 million² deaths, respectively, each year. “ZOLL is excited to work with Wallaby to further expand the use of the Thermogard XP® in China, allowing more patients to benefit from high-quality targeted temperature management (TTM),” said Neil Johnston, President, ZOLL Circulation.